Teens Taking Charge: Managing Cancer Online
7. Oktober 2019 aktualisiert von: Jennifer Stinson, The Hospital for Sick Children
Teens Taking Charge: A Pilot Randomized Controlled Trial of an Online Self-Management and Transitional Care Program for Youth With Cancer
Cancer is the most common potentially fatal disease of adolescence and the Internet represents an ideal means to deliver education, self-monitoring capabilities, and social support to enhance disease self-management by adolescents with cancer.
While two interactive coping websites exist for young people with cancer, they are: (1) not interactive, (2) do not focus on helping youth gain skills for transition and independence, and (3) do not provide opportunities for meaningful social support.
In summary, there is a crucial need to develop a comprehensive interactive Internet-based self-management program targeting AWC that is comprised of cancer education, self-management skills, and opportunities for social support, and that is cost-effective.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Overall aim of this program of research is to develop and evaluate the "Teens Taking Charge: Managing Cancer Online" Internet intervention that will help AWC to better cope with their disease, improve their HRQL, and enhance readiness to transition to adult health care using a sequential phased approach.
The first phase of this project has determined the self-management and transitional care needs of adolescents with cancer.
The second phase consisted of website development and usability testing to ensure the website is easy to use and understand, and is efficient and satisfying to complete.
Subsequently, we will assess the feasibility of the program and the outcomes from the use of the site in a randomized controlled trial (RCT) pilot study (Phase 3).
This will inform the design and methods of the main trial, and will permit us to obtain estimates of treatment effects on AWC health outcomes to inform the calculation of an appropriate sample size for the future definitive RCT (Phase 4).
The focus of this study is Phase 3. Phase 4 will be a multicentre randomized controlled trial to assess outcomes for teens that complete the intervention as compared to those of an attention control group.
Studientyp
Interventionell
Einschreibung (Tatsächlich)
73
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
Ontario
-
Hamilton, Ontario, Kanada, L8S 4K1
- McMaster Children's Hospital
-
Ottawa, Ontario, Kanada, K1H 8L1
- Children's Hospital Eastern Ontario
-
-
Quebec
-
Montreal, Quebec, Kanada, H3T 1C5
- CHU Sainte-Justine
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
12 Jahre bis 18 Jahre (Kind, Erwachsene)
Akzeptiert gesunde Freiwillige
Nein
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
Parents and adolescents will be eligible to participate if the adolescents are:
- between 12-18 years of age
- diagnosed with cancer (at least 3 months from diagnosis)
- on active treatment
- able to speak and read English and/or French at a Grade 6 level
Exclusion Criteria:
Adolescents will be excluded if they:
- have major cognitive impairments
- have reduced executive function that may impact their ability to understand and use the online program
- are terminal/palliative as determined by their oncologist Parents/caregivers are not eligible to participate in the study alone (without an adolescent)
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Kontrollgruppe
|
The control group is designed to control for the potential effects on outcomes of time, attention and computer use during the intervention.
In addition to standard medical care, adolescents in the attention control group will be provided with access to a self-guided patient education study website, which will have two components: basic patient educational materials about Cancer ("Cancer Resource Centre") and online assessments.
|
|
Experimental: Experimentelle Gruppe übernehmen
|
n addition to standard medical care, adolescents in the experimental group will receive the "Taking Charge: Managing Cancer Online" Internet self-management program.
The intervention is a 12-module interactive multi-component treatment protocol that consists of Cancer-specific education, self-management strategies, and social support that is available in English and French.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Participant Accrual and Dropout Rates
Zeitfenster: 12 weeks
|
These rates will be centrally tracked by the Clinical Research Project Coordinator
|
12 weeks
|
|
Fidelity (Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures)
Zeitfenster: 12 weeks
|
Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures will be tracked throughout the study by the Clinical Research Project Coordinator
|
12 weeks
|
|
Acceptability and Satisfaction with Intervention (rate their acceptability of and satisfaction with the intervention)
Zeitfenster: 12 weeks
|
Post-treatment, adolescents with cancer and their parents in the intervention group will rate their acceptability of and satisfaction with the intervention
|
12 weeks
|
|
Engagement with Intervention (Google Analytics will be used to track patterns of website program usage)
Zeitfenster: 12 weeks
|
Google Analytics will be used to track patterns of website program usage by adolescents with cancer and their parents
|
12 weeks
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Knowledge (Adolescent Cancer Knowledge Questionnaire)
Zeitfenster: 12 weeks
|
Measured using the Adolescent Cancer Knowledge Questionnaire, a 15-item tool that assesses cancer-specific knowledge.
|
12 weeks
|
|
Self-Efficacy (Generalized Self-Efficacy-Sherer Scale)
Zeitfenster: 12 weeks
|
Measured by the Generalized Self-Efficacy-Sherer Scale, a 12-item scale that requires adolescents to indicate their level of agreement with a series of statements about self-efficacy.
|
12 weeks
|
|
Treatment adherence (Medication Adherence Scale)
Zeitfenster: 12 weeks
|
Measured with the Medication Adherence Scale, a 4-item scale for assessing self-reported adherence.
|
12 weeks
|
|
Physical Symptoms - Pain (short form Brief Pain Inventory (BPI)
Zeitfenster: 12 weeks
|
Measured using the short form Brief Pain Inventory (BPI), a 15-item measure that includes scales for measuring pain intensity, impact of pain on functioning and well being, and pain interference.
|
12 weeks
|
|
Physical Symptoms - Fatigue (PedsQL Multidimensional Fatigue Module)
Zeitfenster: 12 weeks
|
Measured using the PedsQL Multidimensional Fatigue Module, an 18-item scale with validated versions for child report (ages 8-12 years), teen report (ages 13-18 years), and parental report for children and teens.
|
12 weeks
|
|
Emotional symptoms (Hospital Anxiety and Depression Scale (HADS)
Zeitfenster: 12 weeks
|
Measured using the Hospital Anxiety and Depression Scale (HADS), a 14-item measure for individuals aged >12 years, which can be completed within 2-5 minutes.
|
12 weeks
|
|
Social functioning (Perceived Social Support from Friends (PSS-Fr) Scale)
Zeitfenster: 12 weeks
|
Measured with the Perceived Social Support from Friends (PSS-Fr) Scale, a 20-item scale that assesses the extent to which an individual perceives that their friends fulfill their needs for support.
|
12 weeks
|
|
Transition readiness (Cancer Transition Scales)
Zeitfenster: 12 weeks
|
Measured with the Cancer Transition Scales, which include sub-scales for 'cancer worry' (6 items), 'self-management skills' (15 items), and 'expectations' (12 items).
|
12 weeks
|
|
Health Related Quality of Life (PedsQL Cancer Module)
Zeitfenster: 12 weeks
|
measured with the PedsQL Cancer Module, a 27-item scale, which has validated versions for child, teen, and parental report, and the Health Utility Index [HUI].
|
12 weeks
|
|
Cost effectiveness (ascertaining direct health care costs and family out of pocket costs)
Zeitfenster: 12 weeks
|
Measured by ascertaining direct health care costs and family out of pocket costs related to cancer care incurred over the 12-week study period using the Health Care Utilization form modified from the Ambulatory and Home Care Record84-90 as well as direct costs related to the online intervention technology, intervention training and personnel.
Quality adjusted life years will be calculated using the HUI to determine the incremental cost-effectiveness
|
12 weeks
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Jennifer N Stinson, PhD, CPNP, The Hospital for Sick Children
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
1. Januar 2016
Primärer Abschluss (Tatsächlich)
1. April 2019
Studienabschluss (Tatsächlich)
1. April 2019
Studienanmeldedaten
Zuerst eingereicht
17. November 2014
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
21. November 2014
Zuerst gepostet (Schätzen)
24. November 2014
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
9. Oktober 2019
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
7. Oktober 2019
Zuletzt verifiziert
1. Oktober 2019
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- 1000045896
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .